Data / Drug companies / Ajinomoto Health & Nutrition North America Inc.
Ajinomoto Health & Nutrition North America Inc.: 23 products in the FDA NDC directory, labeler code 51495
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Ajinomoto Health & Nutrition North America Inc. (labeler code 51495) lists 23 products in the FDA National Drug Code Directory. By type: 15 bulk ingredients, 8 drugs for further processing. Its main marketing category is bulk ingredients. The newest product started marketing on July 16, 2026.
The request: Watch Ajinomoto Health & Nutrition North America Inc. (FDA labeler code 51495): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 51495
- Products in commercial distribution
- 23
- Packages
- 23
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Started marketing in the last 12 months
- 1
- Earliest marketing start
- January 2, 1995
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 15 | 65.2% |
| Drugs for further processing | 8 | 34.8% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 15 | 65.2% |
| Drugs for further processing | 8 | 34.8% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 23 | 100% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| L-cystine dihydrochloride | 51495-911 | Powder | Bulk ingredients | July 16, 2026 |
| Amino acid mixture mix d (clinimix hp) | 51495-037 | Powder | Drugs for further processing | March 5, 2025 |
| Amino acid mixture mix d | 51495-034 | Powder | Drugs for further processing | March 5, 2025 |
| L-tryptophan | 51495-931 | Powder | Bulk ingredients | October 1, 2022 |
| L-threonine | 51495-930 | Powder | Bulk ingredients | October 1, 2022 |
| L-histidine | 51495-916 | Powder | Bulk ingredients | October 1, 2022 |
| L-valine | 51495-833 | Powder | Bulk ingredients | October 1, 2022 |
| L-tryptophan | 51495-831 | Powder | Bulk ingredients | October 1, 2022 |
| L-serine | 51495-829 | Powder | Bulk ingredients | October 1, 2022 |
| L-proline | 51495-828 | Powder | Bulk ingredients | October 1, 2022 |
| Leucine | 51495-822 | Powder | Bulk ingredients | October 1, 2022 |
| Histidine | 51495-816 | Powder | Bulk ingredients | October 1, 2022 |
| L-tryptophan | 51495-731 | Powder | Bulk ingredients | October 1, 2022 |
| Amino acid mixture blend pmcb - pediatric blend | 51495-205 | Powder | Drugs for further processing | October 1, 2022 |
| Amino acid mixture blend f | 51495-203 | Powder | Drugs for further processing | October 1, 2022 |
| Amino acid mixture blend d | 51495-201 | Powder | Drugs for further processing | October 1, 2022 |
| Amino acid mixture cs-tb | 51495-199 | Powder | Drugs for further processing | October 1, 2022 |
| Amino acid mixture 219 (mix c) | 51495-178 | Powder | Drugs for further processing | October 1, 2022 |
| L-proline | 51495-028 | Powder | Bulk ingredients | October 1, 2022 |
| L-lysine acetate | 51495-024 | Powder | Bulk ingredients | October 1, 2022 |
| L-histidine monohydrochloride monohydrate | 51495-817 | Powder | Bulk ingredients | January 4, 2008 |
| Alanine | 51495-001 | Powder | Bulk ingredients | June 1, 1998 |
| Amino acid mixture 297 (clinisol) | 51495-181 | Powder | Drugs for further processing | January 2, 1995 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.